Chimeric Therapeutics Limited (ASX:CHM)
0.0050
0.00 (0.00%)
Jul 9, 2025, 4:10 PM AEST
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 11.08 million as of July 8, 2025. Its market cap has decreased by -43.73% in one year.
Market Cap
11.08M
Enterprise Value
6.02M
Revenue
2.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 11.08M, a decrease of -88.63%. That is a compound annual growth rate of -38.51%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 8, 2025 | 11.08M | 0.54% |
Dec 31, 2024 | 11.02M | -56.60% |
Dec 29, 2023 | 25.40M | -27.35% |
Dec 30, 2022 | 34.97M | -59.93% |
Dec 31, 2021 | 87.26M | -10.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 117.55B |
Pro Medicus | 32.16B |
Cochlear | 19.68B |
Sonic Healthcare | 13.42B |
Ramsay Health Care | 9.03B |
Telix Pharmaceuticals | 8.19B |
Ansell | 4.54B |
Regis Healthcare | 2.27B |